Showing 221 - 240 results of 3,139 for search '"Amyloid beta"', query time: 0.56s Refine Results
  1. 221
  2. 222
  3. 223

    Association of walking energetics with amyloid beta status: Findings from the Baltimore Longitudinal Study of Aging by Ryan J. Dougherty, Janani Ramachandran, Fangyu Liu, Yang An, Amal A. Wanigatunga, Qu Tian, Murat Bilgel, Eleanor M. Simonsick, Luigi Ferrucci, Susan M. Resnick, Jennifer A. Schrack

    Published 2021-01-01
    “…We investigated the cross‐sectional association between the energetic cost of walking, gait speed, and amyloid beta (Aβ) status (+/−) in older adults. Methods One hundred forty‐nine cognitively normal adults (56% women, mean age 77.5 ± 8.4 years) completed customary‐paced walking assessments with indirect calorimetry and 11C‐Pittsburgh compound B positron emission tomography. …”
    Get full text
    Article
  4. 224
  5. 225
  6. 226
  7. 227
  8. 228
  9. 229

    An atlas of amyloid aggregation: the impact of substitutions, insertions, deletions and truncations on amyloid beta fibril nucleation by Mireia Seuma, Ben Lehner, Benedetta Bolognesi

    Published 2022-11-01
    “…By comprehensively mapping the impact that different classes of mutations (substitutions, insertions, deletions) have on the ability of the amyloid beta peptide to nucleate amyloids, the authors identify a large set of likely pathogenic variants of amyloid beta that are specifically enriched at its polar N-terminal region.…”
    Get full text
    Article
  10. 230
  11. 231
  12. 232
  13. 233

    Allium roseum L. extract inhibits amyloid beta aggregation and toxicity involved in Alzheimer's disease. by Abdelbasset Boubakri, Manuela Leri, Monica Bucciantini, Hanen Najjaa, Abdelkarim Ben Arfa, Massimo Stefani, Mohamed Neffati

    Published 2020-01-01
    “…In the present study, the inhibition of amyloid beta protein toxicity by the ethanolic extract of this plant is investigated for the first time. …”
    Get full text
    Article
  14. 234

    Computational identification of potential multitarget treatments for ameliorating the adverse effects of amyloid-beta on synaptic plasticity by Thomas J. Anastasio

    Published 2014-05-01
    “…The leading hypothesis on Alzheimer Disease (AD) is that it is caused by buildup of the peptide amyloid-beta (Abeta), which initially causes dysregulation of synaptic plasticity and eventually causes destruction of synapses and neurons. …”
    Get full text
    Article
  15. 235
  16. 236

    Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1–42 in Alzheimer’s disease by Emre Fertan, William H. Gendron, Aimée A. Wong, Gabrielle M. Hanson, Richard E. Brown, Ian C. G. Weaver

    Published 2023-02-01
    “…Since Igf2 is an imprinted gene, we examined age and sex differences in the relationship between amyloid-beta 1–42 (Aβ 42 ) accumulation and epigenetic regulation of the Igf2/H19 gene cluster in cerebrum, liver, and plasma of young and old male and female 5xFAD mice, in frontal cortex of male and female AD and non-AD patients, and in HEK293 cell cultures. …”
    Get full text
    Article
  17. 237

    The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer’s disease mutations by Mireia Seuma, Andre J Faure, Marta Badia, Ben Lehner, Benedetta Bolognesi

    Published 2021-02-01
    “…Plaques of the amyloid beta (Aß) peptide are a pathological hallmark of Alzheimer’s disease (AD), the most common form of dementia. …”
    Get full text
    Article
  18. 238
  19. 239

    Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls. by Thomas J Esparza, Mihika Gangolli, Nigel J Cairns, David L Brody

    Published 2018-01-01
    “…An unanswered question regarding Alzheimer disease dementia (ADD) is whether amyloid-beta (Aβ) plaques sequester toxic soluble Aβ species early during pathological progression. …”
    Get full text
    Article
  20. 240

    The effect of apelin-13 on memory of scopolamine-treated rats and accumulation of amyloid-beta plaques in the hippocampus by Maryam Azhir, Sara Gazmeh, Leila Elyasi, Mehrdad Jahanshahi, Behnaz Bazrafshan

    Published 2023-01-01
    “…Regarding histological analysis, Congo red staining of the hippocampal sections was done, and immunoblotting was used to determine apoptotic biochemical markers, including caspase 3, cytochrome C, and congophilic amyloid-beta plaques. Results: Apelin–13 alleviated scopolamine-related passive avoidance memory impairment and reduced the number of congophilic amyloid-beta plaques in the hippocampus (all P<0.001). …”
    Get full text
    Article